Geode Capital Management, LLC Alaunos Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.04 - $0.13 $3,715 - $12,074	92,878 Added 4.29%	2,256,351 $157,000
Q3 2023 Nov 13, 2023	SELL	$0.12 - $0.5 $10,914 - $45,476	-90,953 Reduced 4.03%	2,163,473 $281,000
Q2 2023 Aug 11, 2023	BUY	$0.43 - $0.65 $50,647 - $76,560	117,786 Added 5.51%	2,254,426 $1.15 Million
Q1 2023 May 15, 2023	BUY	$0.46 - $0.81 $19,458 - $34,264	42,302 Added 2.02%	2,136,640 $1.35 Million
Q4 2022 Feb 13, 2023	BUY	$0.5 - $261.0 $8,920 - $4.66 Million	17,840 Added 0.86%	2,094,338 $1.36 Million
Q3 2022 Nov 14, 2022	BUY	$1.04 - $322.5 $1,748 - $542,122	1,681 Added 0.08%	2,076,498 $3.57 Million
Q2 2022 Aug 12, 2022	SELL	$0.41 - $1.24 $595,165 - $1.8 Million	-1,451,623 Reduced 41.16%	2,074,817 $2.57 Million
Q1 2022 May 13, 2022	SELL	$0.62 - $1.17 $33,471 - $63,164	-53,987 Reduced 1.51%	3,526,440 $2.3 Million
Q4 2021 Feb 11, 2022	BUY	$1.09 - $1.89 $262,564 - $455,272	240,885 Added 7.21%	3,580,427 $3.9 Million
Q3 2021 Nov 12, 2021	SELL	$1.44 - $2.73 $305,520 - $579,215	-212,167 Reduced 5.97%	3,339,542 $6.08 Million
Q2 2021 Aug 13, 2021	BUY	$2.63 - $3.67 $43,784 - $61,098	16,648 Added 0.47%	3,551,709 $9.38 Million
Q1 2021 May 12, 2021	BUY	$2.82 - $5.6 $1.26 Million - $2.5 Million	446,956 Added 14.47%	3,535,061 $12.7 Million
Q4 2020 Feb 12, 2021	BUY	$2.09 - $3.09 $269,338 - $398,208	128,870 Added 4.35%	3,088,105 $7.78 Million
Q3 2020 Nov 13, 2020	BUY	$2.39 - $3.43 $101,281 - $145,353	42,377 Added 1.45%	2,959,235 $7.46 Million
Q2 2020 Aug 13, 2020	BUY	$2.2 - $3.71 $552,204 - $931,217	251,002 Added 9.42%	2,916,858 $9.57 Million
Q1 2020 May 14, 2020	BUY	$1.9 - $4.98 $833,904 - $2.19 Million	438,897 Added 19.71%	2,665,856 $6.53 Million
Q4 2019 Feb 13, 2020	BUY	$3.95 - $5.35 $554,765 - $751,391	140,447 Added 6.73%	2,226,959 $10.5 Million
Q3 2019 Nov 12, 2019	BUY	$4.13 - $6.94 $335,888 - $564,423	81,329 Added 4.06%	2,086,512 $8.93 Million
Q2 2019 Aug 14, 2019	BUY	$3.98 - $6.2 $988,341 - $1.54 Million	248,327 Added 14.13%	2,005,183 $11.7 Million
Q1 2019 May 14, 2019	BUY	$2.0 - $4.4 $409,680 - $901,296	204,840 Added 13.2%	1,756,856 $6.76 Million
Q4 2018 Feb 13, 2019	BUY	$1.61 - $3.62 $233,657 - $525,366	145,129 Added 10.32%	1,552,016 $2.9 Million
Q3 2018 Nov 13, 2018	BUY	$2.26 - $3.27 $124,159 - $179,647	54,938 Added 4.06%	1,406,887 $4.5 Million
Q2 2018 Aug 14, 2018	BUY	$3.02 - $4.94 $498,248 - $815,016	164,983 Added 13.9%	1,351,949 $4.08 Million
Q1 2018 May 15, 2018	BUY	$3.46 - $5.14 $91,042 - $135,248	26,313 Added 2.27%	1,186,966 $4.65 Million
Q4 2017 Feb 13, 2018	BUY	$4.0 - $6.54 $90,300 - $147,640	22,575 Added 1.98%	1,160,653 $4.81 Million
Q3 2017 Nov 14, 2017	BUY	$4.99 - $6.57 $129,490 - $170,491	25,950 Added 2.33%	1,138,078 $6.99 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,112,128	1,112,128 $6.92 Million

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account